Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-25 @ 9:32 PM
Study NCT ID:
NCT01474551
Status:
TERMINATED
Last Update Posted:
2015-11-18
First Post:
2011-11-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-15
First Submit QC Date:
None
Study First Post Date:
2011-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-15
Results First Submit QC Date:
None
Results First Post Date:
2015-04-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-20
Last Update Post Date:
2015-11-18
Last Update Post Date Type:
ESTIMATED